Overview

Trial of Imatinib for Hospitalized Adults With COVID-19

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This study is a randomized Double-Blind Placebo-Controlled Trial on the Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19
Phase:
Phase 3
Details
Lead Sponsor:
University of Maryland, Baltimore
Treatments:
Imatinib Mesylate